Annals of Urologic Oncology

Submit Manuscript

Editorial Board

Editors-in-Chief
  • Sanjay Gupta, Ph.D.

Department of Urology, Case Western Reserve University & UH Cleveland Medical Center, Cleveland, OH, USA.

  • Jae Y. Ro, Ph.D.

Department of Pathology and Genomic Medicine, Houston Methodist Hospital and Weill Medical College of Cornell University, Houston, TX, USA.

Prostate Cancer Group
  • Yuzhuo Wang, Ph.D.
Distinguished Scientist in BC Cancer Agency; Senior Scientist in Vancouver Prostate Centre; Professor in Department of Urologic Sciences, Faculty of Medicine, University of British Columbia; Fellow in the Canadia Academy of Health Sciences, Vancouver, Canada.
  • Jie Gu, Ph.D.
Associate Professor, School of Life Sciences, Jiangsu University, Zhenjiang, China.
  • Jagadananda Ghosh, M.D.
Departments of Urology and The Josephine Ford Cancer Center, Henry Ford Health System, Detroit, Michigan, MI, USA.
  • Sanjay Gupta, Ph.D.
Department of Urology, Case Western Reserve University&UH Cleveland Medical Center, Cleveland, USA.
  • Youqiang Ke, Ph.D., DVM.
Professor & Director in Molecular Pathology, Dept. of Mol. & Clinic Cancer Medicine, Liverpool University, UK.
  • George A. Asare, Ph.D.
Chemical Pathology Unit, Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana.
  • Jae Y. Ro, Ph.D.
Department of Pathology and Genomic Medicine, Houston, TX, USA; Weill Cornell Medical College of Cornell University, Houston, TX, USA.
  • Dr. Paola Gazzaniga
Circulating Tumor Cells Unit, Dept. Molecular Medicine, Viale Regina Elena 324, 00161, Sapienza University of Rome, Roma, Italy.
  • Dr. Aline Gomes de Souza
Laboratory of Nanobiotechnology, Institute of Genetics and Biochemistry, Federal University of Uberlândia (UFU), 38400-902 Uberlândia, MG, Brazil.
  • Shahriar Koochekpour, M.D., Ph.D.
Professor of Cancer Genetics and Genomics, Oncology, and Urology, Departments of Cancer Genetics and Genomics and Urology, Center for Genetics and Pharmacology, Roswell Park, Comprehensive Cancer Center, Buffalo, NY, USA.
  • Rosanna Barzanti Paciucci, Ph.D.
Lab. Cell Signaling and Cancer Progression, Biomedical Research in Urology, Vall d'Hebron , Research Institute, Spain.
  • Edwin M Posadas, M.D.
Clinical Associate Professor, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA.
  • Zhenbang Chen, Ph.D.
Department of Biochemistry, Cancer Biology, Neuroscience & Pharmacology, WBS Building, Room 2133 (Office) and 2139 (Lab), Meharry Medical College, USA.
  • Yujiang Fang, M.D., Ph.D.
Academic Pathologist and Assistant Professor, Dept. of Microbiology, Immunology and Pathology, College of Osteopathic Medicine, Des Moines University, Des Moines, Iowa, USA.
Adjunct Faculty, Division of Urology, Department of Surgery, University of Missouri and Ellis Fischel Cancer Center, University of Missiouri, MO, USA.
  • Finn Edler von Eyben, Ph.D., M.D.
Center of Tobacco Control Research, Odense, Denmark.
  • Ibrahim Turan, Ph.D.
Faculty of Engineering and Natural Science, Department of Genetic and Bioengineering, Gumushane Univesity, Turkey.
  • Dr. Inés Rivero Belenchón

Urology and Nephrology Department, University Hospital Virgen del Rocío, Biomedical Institute of Seville (IBiS)/University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.

Kidney Cancer Group
  • Mohamed Alsharedi, M.D.

Assistant Professor of Medicine, Department of Hematology/Oncology, Joan C. Edwards School of Medicine Marshall University, Edwards Comprehensive Cancer Center at Pleasant Valley Hospital, Huntington, WV, USA.

  • Dr. Guillermo de velasco
Medical Oncologist, Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain.
  • Olivier Cuvillier, Ph.D.
IPBS, Institute of Pharmacology and Structural Biology, Department of Cancer Biology, CNRS, France.
  • Bogomir Milojevic, M.D., Ph.D.
Clinic of Urology, Clinical Center of Serbia, Belgrade, Serbia, Faculty of Medicine, University of Belgrade, Serbia.
  • Chi-Fai Ng, M.D.
Division of Urology, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Dr. Wenhui Weng
Department of Chemical Engineering and Biotechnology, and Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taiwan, China.
  • Dr. Maria I. Volkova
Senior researcher of Dept. of Urology N.N. Blokhin Cancer Center, Moscow, Russia.
  • Maria Giuseppa Vitale, Ph.D.
Azienda Ospedaliera Universitaria di Modena, Modena, Italy.
  • Daniel Keizman, M.D.

Department of Oncology, Meir Medical Center, Kfar Saba, Israel.

  • C. Danny Darlington

Urology in Pondicherry Institute of Medical Sciences, Pondicherry, India.

Bladder Cancer Group
  • Sriram Krishnamoorthy, M.D.

Department of Urology and Renal transplantation, Sri Ramachandra Medical College & Research Institute, Chennai, Tamil Nadu, India.

  • Mohammad O. Hoque, DDS, Ph.D.

Associate Professor, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

  • Chien-Feng Li, Ph.D.
Chair, Department of Pathology, Chi Mei Medical Center, Taiwan, China.
  • Yu-Li Su, M.D.

Medical Oncologist, Kaohsiung Chang Gung Memorial Hospital, Taiwan, China.

  • Shilpa Gupta, M.D.
Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Ghulam Nabi, Ph.D., M.D.
Professor in surgical uro-oncology, Hon. consultant urological surgeon, Clinical Head of Division of Cancer Research, Lead for Minimally Invasive Surgery in Urological Cancers, Chair Tayside Urological Cancer Network (TUCAN), University of Dundee, Scotland, UK.
  • Dr. Sezgin Gunes

Department of Medical Biology and Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.

  • Rama Mittal, M.D.
Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Uttar Pradesh, India.
  • Song Wu, Ph.D., M.D.

Chief scientist of National key research and development plan Vice President of The Affiliated Third Hospital of Shenzhen University, China.

  • Wei Li, M.D.

Department of Urology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.

  • Aifang Tang, M.D.
Shenzhen Second People’s Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Olga Antonova, M.D., Ph.D.

Department of Medical Genetics, Medical University-Sofia, Bulgaria.

  • Dr. Mohamed Mohamed Elawdy

Research instructor, Ministry of Health, Oman, Chairman, Scientific and Research Committees, Oman Urology Association, Oman.

  • James Green, M.D.

Whipps Cross Hospital, Barts NHS Trust, London, UK.

  • Dr. Yu-Guang Tan

Department of Urology, Singapore General Hospital, Singapore.

Oncology Treatment Group
  • Kongming Wu, Ph.D., M.D.
Professor and Vice Director Department of Oncology, Tongji Hospital Huazhong University of Science and Technology, Wuhan, China, Nationality: USA.
  • Alfredo Budillon, M.D., Ph.D.
Chief. Experimental Pharmacology Unit, Department of Research, Istituto Nazionale Tumori- IRCCS G. Pascale, Via M. Semmola, 80131 Napoli, Italy.
  • Yusuf Tutar, Ph.D.
Professor of Faculty of Pharmacy, Cumhuriyet University, Turkey.
  • Alba Fiorentino, M.D.
Chief of Radiation Oncology , Regional General Hospital “Miulli”, Acquaviva delle fonti (BA), Italy.
  • Dr. Ilias Elmouki

Hassan II University of Casablanca, Casablanca, Morocco.

  • Dr. Ayesha Sohail
Department of Mathematics, Comsats Institute of Information Technology, Lahore, Pakistan.
  • Charles Mupamombe, M.D.
Suny Downstate Med Ctr, Brooklyn, NY, USA.
  • Dr. Zhao-Li Zhou
School of Pharmacy, Shanghai Key Laboratory for Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Dr. Song Yong Sang
President, International Society of Precision Cancer Medicine, Seoul National University, Korea.
  • Arpit Rao, M.D.

Associate Professor, Division of Hematology, Oncology and Transplantation; Chair, M-Health/Fairview Oncology Quality and Safety Committee, University of Minnesota Masonic Cancer Center, M.N., USA.

  • Dr. Uma Harihran

Assistant Professor, Department of Anaesthesia and Intensive Care, PGIMER, Dr RML Hospital, India.

  • Dr. Ayşegül Doğan

Faculty of Engineering and Architecture, Department of Genetics and Bioengineering, Yeditepe University, Istanbul, Turkey.

Newly Added Editorial Member
  • Yongbao Wei M.D.
Department of Urology, Fujian Medical University Teaching Hospital, Fujian Provincial Hospital, Fuzhou, Fujian, China.
  • Jing Huang Ph.D.
College of Environmental and Biological Engineering, Putian University, Putian, China.
  • Yan Zhao M.D.
Xuzhou Cancer Hospital, Jiangsu, China.
  • Junzheng Yang
Director of Pharmacology Department of Guangdong nephrotic drug Engineering Technology Research Center, Consun Pharmaceutic Group.
  • Wen Xiao, M.D.
Urology Department, Wuhan Union Hospital, Wuhan, China.
  • Saime Ozbek Sebin, M.D., Ph.D.
Department of Physiology, Faculty of Medicine, Ataturk University, 25240, Erzurum, Turkey.